Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients

Osteoarthritis and Cartilage

Volumn 18, Issue 1, 2010, Pages 82-87

  Gao, S G ^a   Li, K H ^a   Zeng, K B ^a,b   Tu, M ^a,c   Xu, M ^a   Lei, G H ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Xiangtan Central Hospital   (China)

^c Second People's Hospital of Jingmen   (China)

Author keywords

Articular cartilage; Osteoarthritis; Osteopontin; Synovial fluid

Indexed keywords

OSTEOPONTIN;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JOINT DESTRUCTION; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNOVIAL FLUID LEVEL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; OSTEOPONTIN; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID;

EID: 72149123652     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2009.07.009     Document Type: Article

References (31)

1. Sodek J., Ganss B., and McKee M.D. Osteopontin. Crit Rev Oral Biol Med 11 (2000) 279-303
2. Xie Y., Sakatsume M., Nishi S., Narita I., Arakawa M., and Gejyo F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60 (2001) 1645-1657
3. Denhardt D., and Noda M. Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl 30-31 (1998) 92-102
4. Gravallese E.M. Osteopontin: a bridge between bone and the immune system. J Clin Invest 112 (2003) 147-149
5. O'Regan A.W., Nau G.J., Chupp G.L., and Berman J.S. Osteopontin (Eta-1) in cell6 mediated immunity: teaching an old dog new tricks. Immunol Today 21 (2000) 475-478
6. McKee M.D., and Nanci A. Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair. Microsc Res Tech 33 2 (1996) 141-164
7. Standal T., Borset M., and Sundan A. Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol 26 3 (2004) 179-184
8. Chellaiah M.A., and Hruska K.A. The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcif Tissue Int 72 3 (2003) 197-205
9. Suzuki K., Zhu B., Rittling S.R., Denhardt D.T., Goldberg H.A., McCulloch C.A., et al. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. J Bone Miner Res 17 8 (2002) 1486-1497
10. Ruoslahti E., and Pierschbacher M.D. New perspectives in cell adhesion: RGD and integrins. Science 238 (1987) 491-497
11. Attur M.G., Dave M.N., Stuchin S., Kowalski A.J., Steiner G., Abramson S.B., et al. Osteopontin: an intrinsic inhibitor of inflammation in cartilage. Arthritis Rheum 44 (2001) 578-584
12. Pullig O., Weseloh G., Gauer S., and Swoboda B. Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage. Matrix Biol 19 (2000) 245-255
13. McKee M.D., Glimcher M.J., and Nanci A. High-resolution immunolocalization of osteopontin and osteocalcin in bone and cartilage during endochondral ossification in the chicken tibia. Anat Rec 234 (1992) 479-492
14. Daheshia M., and Yao J.Q. The interleukin 1beta pathway in the pathogenesis of osteoarthritis. J Rheumatol 35 12 (2008) 2306-2312
15. Presle N., Pottie P., Dumond H., Guillaume C., Lapicque F., Pallu S., et al. Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthritis Cartilage 14 (2006) 690-695
16. Andereya S., Streich N., Schmidt-Rohlfing B., Mumme T., Müller-Rath R., and Schneider U. Comparison of modern marker proteins in serum and synovial fluid in patients with advanced osteoarthrosis and rheumatoid arthritis. Rheumatol Int 26 (2006) 432-438
17. Ohshima S., Yamaguchi N., Nishioka K., Mima T., Ishii T., Umeshita-Sasai M., et al. Enhanced local production of osteopontin in rheumatoid joints. J Rheumatol 29 (2002) 2061-2067
18. Petrow P.K., Hummel K.M., Schedel J., Franz J.K., Klein C.L., Müller-Ladner U., et al. Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts. Arthritis Rheum 43 7 (2000) 1597-1605
19. Kaneko S., Satoh T., Chiba J., Ju C., Inoue K., and Kagawa J. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 6 (2000) 71-79
20. Kellgren J.H., and Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16 (1957) 494-502
21. van der Sluijs J.A., Geesink R.G., van der Linden A.J., Bulstra S.K., Kuyer R., and Drukker J. The reliability of the Mankin score for osteoarthritis. J Orthop Res 10 1 (1992) 58-61
22. Yagi R., McBurney D., Laverty D., Weiner S., and Horton W.E. Intrajoint comparisons of gene expression patterns in human osteoarthritis suggest a change in chondrocyte phenotype. J Orthop Res 23 (2005) 1128-1138
23. Xu G., Nie H., Li N., Zheng W., Zhang D., Feng G., et al. Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 115 4 (2005) 1060-1067
24. Chen Y.J., Shen J.L., Wu C.Y., Chang Y.T., Chen C.M., and Lee F.Y. Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis. J Am Acad Dermatol 60 2 (2009) 225-230
25. Denhardt D.T., Giachelli C.M., and Rittling S.R. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 41 (2001) 723-749
26. Ramaiah S.K., and Rittling S. Role of osteopontin in regulating hepatic inflammatory responses and toxic liver injury. Expert Opin Drug Metab Toxicol 3 4 (2007) 519-526
27. Kolb A., Kleeff J., Guweidhi A., Esposito I., Giese N.A., Adwan H., et al. Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions. Cancer Biol Ther 4 7 (2005) 740-746
28. Fedarko N.S., Jain A., Karadag A., Van Eman M.R., and Fisher L.W. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 7 (2001) 4060-4066
29. Song G., Cai Q.F., Mao Y.B., Ming Y.L., Bao S.D., and Ouyang G.L. Osteopontin promotes ovarian cancer progression and cell survival and increases HIF-1alpha expression through the PI3-K/Akt pathway. Cancer Sci 99 10 (2008) 1901-1907
30. Yang G.H., Fan J., Xu Y., Qiu S.J., Yang X.R., Shi G.M., et al. Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection. Oncologist 13 11 (2008) 1155-1165
31. Reiniger I.W., Wolf A., Welge-Lüssen U., Mueller A.J., Kampik A., and Schaller U.C. Osteopontin as a serologic marker for metastatic uveal melanoma: results of a pilot study. Am J Ophthalmol 143 (2007) 705-707